These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 16135498)
1. Should we transplant indolent lymphoma? Nabhan C J Clin Oncol; 2005 Sep; 23(25):6263-4; author reply 6264-6. PubMed ID: 16135498 [No Abstract] [Full Text] [Related]
2. High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT. Kolstad A; Tjønnfjord G; Jønsson V Bone Marrow Transplant; 2008 Sep; 42(6):427-8. PubMed ID: 18587433 [No Abstract] [Full Text] [Related]
3. Comment to: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica 2008; 93:398-403. van der Spek E; van der Griend R Haematologica; 2008 Jul; 93(7):e57; author reply e58. PubMed ID: 18591617 [No Abstract] [Full Text] [Related]
4. Treatment of localized primary gastric lymphoma. Wöhrer S; Troch M; Raderer M J Clin Oncol; 2006 Jun; 24(17):2682; author reply 2682-3. PubMed ID: 16763284 [No Abstract] [Full Text] [Related]
5. Breast cancer following treatment of Hodgkin's disease--more reasons for less radiotherapy? Wolf J; Schellong G; Diehl V Eur J Cancer; 1997 Dec; 33(14):2293-4. PubMed ID: 9616268 [No Abstract] [Full Text] [Related]
6. Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Teta MJ; Lau E; Sceurman BK; Wagner ME Cancer; 2007 Apr; 109(7):1432-8. PubMed ID: 17315168 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome. Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]